Return to Listing

1 result(s) for

PI Name Protocol # Title
Prakash Ambady STUDY00021263 (Advarra IRB IAA) A Phase 2b Trial of the MEK 1/2 Inhibitor (MEKi) PD-0325901 in Adult and Pediatric Patients with Neurofibromatosis Type 1 (NF1) Associated Inoperable Plexiform Neurofibromas (PNs) that are Causing Significant Morbidity
 

You may also qualify for Phase 1 Program trials.

 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080